{"id":"W4388760129","doi":"10.1016/j.fander.2023.09.571","title":"Bimékizumab pour le traitement de patients atteints de maladie de Verneuil modérée à sévère : efficacité et tolérance à 48 semaines de BE HEARD I et II, études multicentriques de phase 3, randomisées, en double aveugle contrôlées par placebo","year":2023,"lang":"fr","type":"article","venue":"Annales de Dermatologie et de Vénéréologie - FMC","topic":"Anorectal Disease Treatments and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Medicine; Gynecology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002330759,0.0007272055,0.002605818,0.000378024,0.000287554,0.0007362899,0.0005394015,0.001015153,0.003380639],"category_scores_gemma":[0.00174782,0.0005260261,0.002246682,0.0003362106,0.0006210174,0.0009919041,0.0002895341,0.002245927,0.0003634326],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000805629,"about_ca_system_score_gemma":0.0007398091,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001063732,"about_ca_topic_score_gemma":0.00193493,"domain_scores_codex":[0.9991238,0.0005149425,0.00006666002,0.0001025084,0.00006816466,0.0001239738],"domain_scores_gemma":[0.9992206,0.0003249513,0.000191235,0.00005969918,0.00004733181,0.0001562962],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9104375,0.004622079,0.0019919,0.001370989,0.001847726,0.00006857532,0.0001297831,0.0007219102,0.005636846,0.0001568427,0.0007814921,0.07223435],"study_design_scores_gemma":[0.8439715,0.1411027,0.009848355,0.0001466133,0.001158805,0.0001116241,0.00006837009,0.0007685359,0.001326,0.0001746651,0.001293012,0.00002974832],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9778774,0.0182155,0.000693193,0.0004178137,0.0002412773,0.0009081699,0.0004538732,0.00006713075,0.001125667],"genre_scores_gemma":[0.9919749,0.004201004,0.0009642362,0.0003902491,0.0001914694,0.0006513242,0.0003362365,0.00001523516,0.001275307],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003380639,"threshold_uncertainty_score":0.01232642,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04664165443581136,"score_gpt":0.3608733981473927,"score_spread":0.3142317437115814,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}